TEL:020-31701980      FAX:020-31701979     E-mail:sales@mx008.com
China Mingxuan
Service Hotline:020-3171980
搜索

News
MX trends
industry trends
fair information
 
Micro-channel
 
Information details You are here:Home >> News >> industry trends
 
After the implementation of the "two-ticket system", the drug cost was reduced to a few hundred yuan
 
Author:中国铭铉 企划部  Release Time:2017-9-8 15:23:14  Number Browse:865
 
Medical network - on September 8th September 1, standing in the liaoning province tumor hospital bone cancer ward of the corridor, see just print payment list, Mr. Sun suddenly discovered that, son small shipment (not her real name), expenses for medicine less: more than 890 dollars of each original a vial of cancer drugs, turned into more than 810 dollars. "This medicine child one course of treatment will use 8, and still be self-funded project, reduce price is to reduce negative Gospel!" Mr. Sun, as he presented the bill to reporters, said with emotion.

Currently, drug procurement "two-ticket" is accelerating to the ground. "There is a lack of intermediate links, which will not only avoid the layers of extra prices caused by the excessive circulation of drugs in the past, but also make regulation more effective." The head of the sichuan provincial health and family planning commission said the "two-ticket system" would make drug circulation more orderly and orderly.

The direct health of drug costs is an important result of the "two-ticket system"

The two ticket-system means the drug manufacturer to the circulation enterprise to open a sale purchase invoice, the circulation enterprise to the medical establishment to open a sale purchase invoice. The relevant state departments launched one of the main purpose of the "two votes", is the hope through the current medicine circulation "two votes" compression widespread multistage distribution system, avoid the circulation layers of premium and cause drug prices artificially high.

According to statistics, as of August 2017, 25 provinces, autonomous regions and municipalities directly under the central government have officially issued the implementation plan for the purchase of two tickets for pharmaceutical purchases. According to the country in the two votes implementation opinions for pushing nationwide in 2018 proposed by the goal of "two votes", "two votes" will soon roll out in more cities and provinces, many pharmaceutical companies also began to adjust its distribution system according to the new policy. At the same time, the "two-ticket system" has also been applied to medical device enterprises that produce medical consumables in some provinces except for pharmaceutical enterprises.

September 1, liaoning public medical institutions (including into the basic drug system management of grassroots medical institutions, village clinics) formal drug purchase full implementation of the "two votes", at present, the implementation of "two votes" has become the access of drug centralized purchasing activities in liaoning province, is not in accordance with the requirements and provisions on major tax illegal cases of pharmaceutical production enterprises, circulation enterprises, the parties will be disqualified from participation in drug centralized procurement and distribution of liaoning province, and included in the liaoning province pharmaceutical sales credit record.

The direct health of the drug is one of the important achievements of the "two-ticket system". "In the process of medicine from the pharmaceutical factory to the hospital, generally speaking, the intermediate circulation link will increase one layer of cost, which will eventually be reflected in the drug purchase price of the hospital. By implementing the "two-ticket system" of drug procurement in public medical institutions, the price of drug purchasing terminals has been reduced by reducing the circulation of the past few cycles or even a dozen cycles. In liaoning province, the director of the department of medical and planning, zhang qiang said.

It is learned that in liaoning province on June 1, the effect of price reduction and standardized management of some medicines has been shown since the start of the trial operation of "two-ticket system" in the provincial public medical institutions. Pointing at the computer screen rows of drug details and price list, tumor, director of the cqi pharmacists Xu Wei told reporters in liaoning province, liaoning province on August 25 in a new round of bidding and procurement of western medicine, only participate in the early stage of the commissioning of the liaoning province tumor hospital to buy drugs, there are 270 varieties over previous prices.

The reporter sees in the drug purchasing list, the price range from several dollars to several dozens yuan, hundreds of yuan, some injection with effective even a single price of 862.2 yuan, a period of treatment, patients with this kind of medicine can only save 3000 multivariate.

For the treatment of breast cancer, gynecological tumor, and non-small cell lung cancer, the use of docetaxel is an example. In the past 20mg, the purchase price of each box was 453.04 yuan, and now it has decreased to 146.67 yuan, a decrease of 67.6%. Using six to nine calculations per patient per month, the drug alone could save nearly 2,000 yuan per month.

How pharmaceutical companies cope with the "two-ticket" system

According to the understanding, the pharmaceutical enterprises have adjusted the distribution system to adapt to the requirements of "two-ticket system", and most of them chose the large pharmaceutical circulation group with wide network coverage to establish distribution relations. According to the two-ticket implementation opinion, the transfer of drugs within the pharmaceutical circulation group to a wholly owned subsidiary or wholly owned subsidiary is not considered a vote. So the future practice of traditional Chinese medicine enterprises are likely to choose those had distribution subsidiaries in many large pharmaceutical circulation group as a dealer, by the broad distribution of the group of medicine circulation distribution network to replace the original two layers of distribution network, and in these large pharmaceutical circulation group cannot cover the distribution area, pharmaceutical companies could choose independent distributors and distribution of products.

This model is the most conforms to the spirit of "two votes implementation opinion", the smallest is also on the compliance risk, but the long-term dependence on these large pharmaceutical circulation group for pharmaceutical companies may have lost the original advantage negotiating position. The practice of TCM enterprises also has some other adjustment measures for the "two-ticket system", such as the self-built sales team of pharmaceutical enterprises and the purchase of distribution enterprises.

For the pharmaceutical industry, the implementation of the "two-ticket system" will force it to change its thinking. For companies with terminal teams, there is no problem with the two-ticket system. Like foreign companies, mainstream companies used to do this. Moreover, large enterprises can also carry out strategic cooperation with large commercial companies. In addition, the exclusive variety also does not need the base price to attract investment, because the enterprise has the expense space to build the team. Those who have neither terminal nor brand name will be sad many times, which will be very helpful to standardize the pharmaceutical production industry.

The medical circulation is all in the sun

It is understood that in the latest round of bidding for liaoning province, drug prices have fallen by 20 to 30 per cent from the previous average, and some medicines have even reached the lowest price in the country. Overall analysis of the industry that drug prices and drug zero rate, reduce the medicine proportion, medicare payments, drug companies, cost accounting, the tender policy reform and a series of "combination" are linked, but "two votes" credit cannot be ignored during commissioning.

"In previous tenders, the final participants were the distribution enterprises directly facing the hospital, which would take into account the cost of the intermediate multi-tier distribution. Now smooth the middle, the water will be squeezed out, and the price of medicine will be relatively low. Liaoning province cancer hospital party committee deputy secretary, deputy director yu tao said.

The implementation of the "two-ticket system" will also crack down on illegal and illegal activities such as "overticket money laundering", tax evasion and non-compliance storage and transportation. "The more of a delivery business, the more layers of regulation that need to be regulated, and the greater the chance of problems outside the regulatory gap. The reduction of intermediate links is not only convenient for supervision, but also reduces the risk of bad storage of drugs in the distribution section because of poor storage conditions. It will be easier and quicker to trace back to the source when problems arise. Yu Tao said.

With the spread of the "two-ticket system", the pharmaceutical distribution industry will be in the industry shuffle. Medicine in liaoning province foreign trade co., LTD., deputy general manager zhang jie, the personage inside course of study thinks, with supervision strengthened, some non-canonical enterprises and varieties of a single, terminal hospital cover or send out shortage of small and medium-sized distribution enterprises, the ebb tide is stronger, more formal enterprise.

"The 'two-ticket' system starts the integration of resources from the manufacturer and regulates behavior and taxation, and has higher requirements for the precision of the service of the enterprise itself." Zhang jie tells a reporter, now before the chick procurement, distribution enterprises need to make sure whether "the first vote" compliance, equivalent to the enterprise source tracing, and through the information technology to put the "first" and "the second ticket" import hospital system, ensure that the entire circulation in the sun.
 
Previous article:The domestic high-end medical device, the heart pacemaker depends on the import situation
Next article:The trade friction of China's pharmaceutical products exports is on the rise
 
Log in  Website Map All right reserved by China Mingxuan, Guangzhou ICP #16026227
    

粤公网安备 44011202000029号